Catálogo de publicaciones - libros
Título de Acceso Abierto
Evaluating Evidence of Mechanisms in Medicine
Veli-Pekka Parkkinen Christian Wallmann Michael Wilde Brendan Clarke Phyllis Illari Michael P Kelly Charles Norell Federica Russo Beth Shaw Jon Williamson
Resumen/Descripción – provisto por la editorial
No disponible.
Palabras clave – provistas por la editorial
Philosophy of Medicine; Epistemology
Disponibilidad
Institución detectada | Año de publicación | Navegá | Descargá | Solicitá |
---|---|---|---|---|
No requiere | 2018 | SpringerLink |
Información
Tipo de recurso:
libros
ISBN impreso
978-3-319-94609-2
ISBN electrónico
978-3-319-94610-8
Editor responsable
Springer Nature
País de edición
Reino Unido
Fecha de publicación
2018
Información sobre derechos de publicación
© The Editor(s) (if applicable) and The Author(s) 2018
Cobertura temática
Tabla de contenidos
Introduction
Veli-Pekka Parkkinen; Christian Wallmann; Michael Wilde; Brendan Clarke; Phyllis Illari; Michael P. Kelly; Charles Norell; Federica Russo; Beth Shaw; Jon Williamson
This chapter introduces the idea of EBM+, which adopts the explicit requirements of EBM, to (1) make all the key evidence explicit and (2) adopt explicit methods for evaluating that evidence. EBM+ then sets out to get us better causal knowledge by explicitly integrating evidence of mechanism alongside evidence of correlation. This chapter summarises some important benefits of including evidence of mechanism, particularly given how highly idealised study populations typically are, and introduces the need to make uses of evidence of mechanism more explicit.
Part I - Why Consider Mechanisms? | Pp. 3-9
An Introduction to Mechanisms
Veli-Pekka Parkkinen; Christian Wallmann; Michael Wilde; Brendan Clarke; Phyllis Illari; Michael P. Kelly; Charles Norell; Federica Russo; Beth Shaw; Jon Williamson
This chapter offers a brief summary of mechanisms, as including complex-system mechanisms (a complex arrangement of entities and activities, organised in such a way as to be regularly or predictably responsible for the phenomenon to be explained) and mechanistic processes (a spatio-temporal pathway along which certain features are propagated from the starting point to the end point). The chapter emphasises that EBM+ is concerned with evidence of mechanisms, not mere just-so stories, and summarises some key roles assessing evidence of mechanisms can play, particularly with respect to assessing efficacy and external validity.
Part I - Why Consider Mechanisms? | Pp. 11-21
How to Consider Evidence of Mechanisms: An Overview
Veli-Pekka Parkkinen; Christian Wallmann; Michael Wilde; Brendan Clarke; Phyllis Illari; Michael P. Kelly; Charles Norell; Federica Russo; Beth Shaw; Jon Williamson
This chapter introduces how to assess evidence of mechanisms, explaining a summary protocol for use of evidence of mechanisms in assessing efficacy, then external validity (developed theoretically in Part III, with tools for implementation offered in Part II). An outline of quality assessment—of a whole body of evidence, rather than individual studies—is given. The chapter finishes with a brief introduction to the ideas developed in Part III: gathering evidence of mechanisms (Chap. ); evaluating evidence of mechanisms (Chap. ); and using evidence of mechanisms to evaluate causal claims (Chap. ).
Part I - Why Consider Mechanisms? | Pp. 23-33
Tools
Veli-Pekka Parkkinen; Christian Wallmann; Michael Wilde; Brendan Clarke; Phyllis Illari; Michael P. Kelly; Charles Norell; Federica Russo; Beth Shaw; Jon Williamson
If theoretical developments in evidence assessment are to prove useful, guidance on implementation is essential, and this chapter fills that need. A variety of tools are offered, which can be used either in isolation, or in the various combinations suggested. The starting point is an tool which should be very widely usable to give a very quick overview. Then two tools are offered for guideline developers for medical practice; these offer improved assessment of evidence of mechanism in assessing clinical trials, and, if needed, in basic science papers. For politicians, journalists, academics, and so on, a critical appraisal tool is offered alongside GRADE-style tables for mechanism assessment. A final tool is designed specifically for public health and social care.
Part II - Tools for Working with Mechanisms | Pp. 37-59
Gathering Evidence of Mechanisms
Veli-Pekka Parkkinen; Christian Wallmann; Michael Wilde; Brendan Clarke; Phyllis Illari; Michael P. Kelly; Charles Norell; Federica Russo; Beth Shaw; Jon Williamson
In this chapter we put forward more theoretical proposals for gathering evidence of mechanisms. Specifically, the chapter covers the identification of a number of mechanism hypotheses, formulation of review questions for search, and then how to refine and present the resulting evidence. Key issues include increased precision concerning the nature of the hypothesis being examined, attention to differences between the study population (or populations) and the target population of the evidence assessors, and being alert for masking mechanisms, which are other mechanisms which may mask the action of the mechanism being assessed. An outline example concerning probiotics and dental caries is given. (Databases that may be helpful for some searches can be found online in ).
Part III - Core Principles | Pp. 63-75
Evaluating Evidence of Mechanisms
Veli-Pekka Parkkinen; Christian Wallmann; Michael Wilde; Brendan Clarke; Phyllis Illari; Michael P. Kelly; Charles Norell; Federica Russo; Beth Shaw; Jon Williamson
In this chapter, we discuss how to evaluate evidence of mechanisms. This begins with an account of how a mechanistic study provides evidence for features of specific mechanism hypotheses, laying out a three step procedure of evaluating: (1) the methods used, (2) the implementation of the methods, and (3), the stability of the results. The next step is to combine those evaluations to present the quality of evidence of the general mechanistic claim.
Part III - Core Principles | Pp. 77-90
Using Evidence of Mechanisms to Evaluate Efficacy and External Validity
Veli-Pekka Parkkinen; Christian Wallmann; Michael Wilde; Brendan Clarke; Phyllis Illari; Michael P. Kelly; Charles Norell; Federica Russo; Beth Shaw; Jon Williamson
Previous chapters in Part III develop accounts of how to gather and evaluate evidence of claims about mechanisms. This chapter explains how this evaluation can be combined with an evaluation of evidence for relevant correlations in order to produce an overall evaluation of a causal claim. The procedure is broken down to address efficacy, external validity, and then the overall presentation of the claim.
Part III - Core Principles | Pp. 91-98
Assessing Exposures
Veli-Pekka Parkkinen; Christian Wallmann; Michael Wilde; Brendan Clarke; Phyllis Illari; Michael P. Kelly; Charles Norell; Federica Russo; Beth Shaw; Jon Williamson
An important problem in causal inference in medicine involves establishing causal relationships between environmental exposures and negative health outcomes. It is typically not possible to use RCTs to solve this problem, for ethical reasons. The approach outlined in this book is compared to two other prominent approaches: the procedures of the International Agency for Research on Cancer (IARC), and SYRINA, a framework for detecting exposures that affect the endocrine system.
Part IV - Particular Applications | Pp. 101-110
Assessing Mechanisms in Public Health
Veli-Pekka Parkkinen; Christian Wallmann; Michael Wilde; Brendan Clarke; Phyllis Illari; Michael P. Kelly; Charles Norell; Federica Russo; Beth Shaw; Jon Williamson
Further considerations need to be borne in mind for evidence appraisal in areas beyond clinical medicine, such as public health. This chapter looks at how public health has treated associations and correlations. Then it examines the importance to public health of mechanisms operating at the group and individual level, concerning social interactions and support, access to socio-sanitary infrastructures, psychological factors, and so on, which have to be explored in the appraisal of public health evidence. Finally, the chapter considers the relationship between biological and social factors, and the difference between mechanisms of disease and mechanisms of prevention.
Part IV - Particular Applications | Pp. 111-120
Particularisation to an Individual
Veli-Pekka Parkkinen; Christian Wallmann; Michael Wilde; Brendan Clarke; Phyllis Illari; Michael P. Kelly; Charles Norell; Federica Russo; Beth Shaw; Jon Williamson
In Sect. , we discussed extrapolation from a study population to a target population. In this chapter, we treat particularisation from a study population to one of its members. In both cases, evidence of similarity of mechanisms plays a crucial role.
Part IV - Particular Applications | Pp. 121-125